Filter News
Area of Research
- (-) Isotopes (5)
- (-) Materials (7)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (6)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Materials for Computing (2)
- National Security (2)
- Neutron Science (11)
- Nuclear Science and Technology (2)
- Supercomputing (17)
News Topics
- (-) Biomedical (11)
- 3-D Printing/Advanced Manufacturing (23)
- Advanced Reactors (4)
- Artificial Intelligence (9)
- Big Data (2)
- Bioenergy (11)
- Biology (4)
- Buildings (5)
- Chemical Sciences (33)
- Clean Water (3)
- Climate Change (6)
- Composites (9)
- Computer Science (18)
- Coronavirus (4)
- Critical Materials (13)
- Cybersecurity (4)
- Decarbonization (8)
- Energy Storage (34)
- Environment (16)
- Exascale Computing (2)
- Frontier (3)
- Fusion (7)
- Grid (5)
- High-Performance Computing (4)
- Irradiation (2)
- Isotopes (33)
- ITER (1)
- Machine Learning (5)
- Materials (73)
- Materials Science (79)
- Mathematics (1)
- Microscopy (27)
- Molten Salt (3)
- Nanotechnology (39)
- National Security (4)
- Net Zero (1)
- Neutron Science (33)
- Nuclear Energy (19)
- Partnerships (11)
- Physics (29)
- Polymers (17)
- Quantum Computing (3)
- Quantum Science (11)
- Renewable Energy (1)
- Security (3)
- Simulation (1)
- Space Exploration (5)
- Summit (2)
- Sustainable Energy (13)
- Transformational Challenge Reactor (3)
- Transportation (14)
Media Contacts
![Seeing the difference Ac-225 could make to cancer patients made Raina Setzer want to come to ORNL to directly work with the isotope. Credit: Allison Peacock/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-11/rs_0.jpg?h=71976bb4&itok=nFsgqwUT)
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
![TIP graphic](/sites/default/files/styles/list_page_thumbnail/public/2023-06/TIPbg_1200.png?h=da33fe38&itok=y7ggwHLV)
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
![Researchers at Oak Ridge National Laboratory probed the chemistry of radium to gain key insights on advancing cancer treatments using radiation therapy. Credit: Adam Malin/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-09/radium_0.jpg?h=dbdf53bf&itok=dMlhyVKO)
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
![MDF Exterior](/sites/default/files/styles/list_page_thumbnail/public/2022-06/2021-p07609.jpg?h=be3e4b3a&itok=YfKK7Wy2)
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
![Coronavirus graphic](/sites/default/files/styles/list_page_thumbnail/public/2020-04/covid19_jh_0.png?h=d1cb525d&itok=PyngFUZw)
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
![From left, ORNL’s Rick Lowden, Chris Bryan and Jim Kiggans were troubled that target discs of a material needed to produce Mo-99 using an accelerator could deform after irradiation and get stuck in their holder. From left, ORNL’s Rick Lowden, Chris Bryan and Jim Kiggans were troubled that target discs of a material needed to produce Mo-99 using an accelerator could deform after irradiation and get stuck in their holder.](/sites/default/files/styles/list_page_thumbnail/public/news/images/2018-P01734.jpg?itok=IbSUl9Vc)
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...